Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
04/2006
04/26/2006EP1049788B1 Protein expression in baculovirus vector expression systems
04/26/2006EP1032697B1 High efficiency retroviral vectors that contain none of viral coding sequences
04/26/2006EP0811057B1 Viral preparations, vectors, immunogens, and vaccines
04/26/2006CN1764719A MELAN-A peptide analogue-virus-like-particle conjugates
04/26/2006CN1764718A Infectious bursal disease virus (IBDV) mutant expressing virus neutralising epitopes specific for classic-and variant ibdv strains
04/26/2006CN1763205A Recombinant chicken Marek's disease virus transfer vector and application thereof
04/26/2006CN1763192A Prawn white spot syndrome virus apoptosis suppressor and preparation and application thereof
04/26/2006CN1763182A Virus removal and inactivation treatment process for preparation of dust mite allergen
04/26/2006CN1763181A Vaccine against mumps containing a JERYL-LYNN virus strain
04/26/2006CN1253561C Process for structuring combined rhabdovirus by high-flux clone
04/26/2006CN1253207C Split enveloped virus preparation
04/25/2006USRE39078 Recombinant adenoviruses for gene therapy in cancers
04/25/2006US7034926 Methods and apparatus for harvesting vaccine from eggs
04/25/2006US7034141 The packaging systems are based on the expression of split-helper functions by coinfecting cells with recombinant vectors, such as recombinant poxvirus vectors
04/25/2006US7033835 Amino acid sequences fused to genetic engineered plant protein; used as antigen, antibodies; inoculation of plant with virus vector; gene expression of fusion protein
04/25/2006US7033833 Polynucleotides encoding carnation senescense-induced EIF-5A
04/25/2006US7033826 Recombinant adenoviruses, use thereof for preparing AAVS, complementary cell line, and pharmaceutical compositions containing said adenoviruses
04/25/2006US7033813 Deactivation vaccine; using critical temperature, critical pressure solvent
04/25/2006US7033797 for identification and vaccination of human papillomavirus;
04/25/2006US7033750 Recombinant P53 adenovirus methods and compositions
04/25/2006US7033749 Detection of preferential nucleotidse sequences; obtain sample, incubate with probe, detect signal, recover nucleotide sequences
04/25/2006CA2236912C Vectors and methods for gene transfer to cells
04/20/2006WO2006040084A1 Method for preparing viral material
04/20/2006US20060084119 Preparing budding virus expressing mammalian transporter having transporter activity by culturing host cell infected with budding virus comprising gene encoding transporter and is recombinantly expressing transporter, expressing transporter on envelope of budding virus released from host cell, harvesting
04/20/2006US20060084091 Methods and compositions for polypeptide engineering
04/20/2006DE102004049290A1 Verfahren zur Herstellung von Virusmaterial A process for the production of virus material
04/20/2006CA2583698A1 Refrigerator-temperature stable influenza vaccine compositions
04/19/2006EP1646715A1 Production of poxviruses with adherent or non adherent avian cell lines
04/19/2006EP1373478B1 Attenuated live vaccine
04/19/2006EP1309680B1 Dna & protein binding miniature proteins
04/19/2006EP1228199B1 Method for directed packaging of molecular substances in protein shells
04/19/2006EP1140161B1 Synthetic virus-like particles with heterologous epitopes
04/19/2006EP1073760B1 Adenovirus mutants with deleted protease gene, complementing cell lines and corresponding vectors for gene transfer
04/19/2006EP0742821B1 Method for preparing a multicombinatorial library of antibody gene expression vectors
04/19/2006CN1761745A A novel human virus causing severe acute respiratory syndrome (SARS) and uses thereof
04/19/2006CN1252273C DNA encoding plant deoxyhypusine synthase, plant eukaryotic intiation factor 5A, transgenic plants and method for controlling senescence and apoptosis in plants
04/19/2006CN1252252C Recombined baculovirus of insect, preparation method and application as insecticide
04/18/2006US7030296 Toxin gene from the bacteria photorhabdus luminescens
04/18/2006US7030234 Non-M, non-O HIV-1 strains, fragments and uses
04/18/2006US7029903 Cold-adapted equine influenza viruses
04/18/2006US7029682 Immunogenic preparation that is recognized as a specific monoclonal antibody and a veterinarily acceptable vehicle or excipient
04/13/2006WO2006038742A1 Recombinant virus and use thereof
04/13/2006WO2006038124A1 Subtype-matched inactivated whole virus vaccines for treating patients with hiv infection
04/13/2006WO2005062820A3 Multi plasmid system for the production of influenza virus
04/13/2006DE10021433B4 Verfahren zur Herstellung eines antiviralen Mittels Process for the preparation of an antiviral agent
04/13/2006CA2582426A1 Subtype-matched inactivated whole virus vaccines for treating patients with hiv infection
04/12/2006EP1645635A2 Replication defective recombinant retroviruses expressing a palliative
04/12/2006EP1644492A2 Modified recombinant vaccinia viruses and other microorganisms, uses thereof
04/12/2006EP1644037A2 Functional influenza virus-like particles (vlps)
04/12/2006EP1644034A1 Packaged virus-like particles
04/12/2006EP1373524B1 Cytomegalovirus intron a fragments
04/12/2006EP1334174B1 Paramyxovirus vector for gene transfer to the cardiovascular system
04/12/2006EP1299130B1 A method of treating and preventing infectious diseases
04/12/2006CN1757725A siRNA capable of inhibiting foot and mouth disease virus replication and infection and its preparation method
04/12/2006CN1250732C 病毒株 Strains
04/12/2006CN1250731C Packaging of positive-strand RNA virus replicon particles
04/12/2006CN1250725C Prodn of attenuated parainfluenza virus vaccines from cloned nucleotide sequences
04/12/2006CN1250287C Application of recombinant adenovirus in treating cerebral ischemia, traumatic restoration and tissue adhesion
04/11/2006US7026154 Method of inactivating enveloped viruses in a viral preparation of non-enveloped viruses
04/11/2006US7026113 Veterinary medicine; vaccine containing mutant gene
04/11/2006US7025968 Identifying viricidal agents which prevent cytomegalo viral infection and distribution; gene expression inhibition
04/11/2006US7025967 Recombinant protein production in bovine adenovirus expression vector system
04/06/2006WO2006036004A1 Telomelysin-gfp gene-containing recombinant virus
04/06/2006WO2006035829A1 Cell for producing retrovirus vector
04/06/2006WO2006034545A1 Variants of hepatitis b virus with resistance to anti-viral nucleoside agents and applications thereof
04/06/2006US20060073164 Dengue and West Nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications
04/06/2006CA2581969A1 Telomelysin-gfp gene-containing recombinant virus
04/06/2006CA2580977A1 Bacteriophages displaying functional enzymes and uses thereof
04/05/2006EP1642966A1 Minus strand rna viral vectors carrying a gene with altered hypermutable regions
04/05/2006EP0772773B1 Src SH3 BINDING PEPTIDES AND METHODS OF ISOLATING AND USING SAME
04/05/2006CN1756837A Animal-free cell culture method
04/05/2006CN1249248C (-)-strand RNA virus vector for nerce cell
04/05/2006CN1249241C HIV-like particles and use thereof
04/05/2006CN1248740C AIDS virus vaccine with use of sendai virus vector
04/04/2006US7022830 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
04/04/2006US7022519 Process control; culture product
04/04/2006US7022500 Humanized immunoglobulins
04/04/2006US7022327 Recombinant birnavirus vaccine
04/04/2006US7022324 Stabilized viral envelope proteins and uses thereof
04/04/2006US7022323 Prevent infections using envelope glycoprotein; binding to antibody
04/04/2006US7022319 Vectors carrying therapeutic genes encoding antimicrobial peptides for gene therapy
04/04/2006CA2278808C Methods for cultivating cells and propagating viruses
04/04/2006CA2187207C Poxvirus-canine distemper virus (cdv) recombinants and compositions and methods employing the recombinants
03/2006
03/30/2006WO2006033999A2 Modified adenovirus containing a fiber replacement protein
03/30/2006WO2005121169A3 Apoptosis-inducing polypeptides
03/30/2006WO2005071093A3 Chimpanzee adenovirus vaccine carriers
03/30/2006US20060067948 Viral vectors
03/30/2006CA2577801A1 Porcine reproductive and respiratory syndrome isolates and methods of use
03/29/2006EP1305402B1 Lipo-viro-particle complexes, preparation method and uses
03/29/2006EP1272676B1 Hiv detection assay and reagents therefor
03/29/2006EP1082446B1 Recombinant aav vectors for gene therapy of hemophilia a
03/29/2006EP1005363B1 Recombinant dimeric envelope vaccine against flaviviral infection
03/29/2006EP0956343B1 Recombinant swinepox virus
03/29/2006CN1754002A Methods and compositions concerning poxviruses and cancer
03/29/2006CN1752209A Bactericidal agent for deactivation of SARS virus and preparing process thereof
03/29/2006CN1247788C Lentivirus-Based gene transfer vectors.
03/29/2006CN1247785C Cytomegalovirus intron A fragments
03/29/2006CN1247775C Attenuated cattle viral diarrhoea virus
03/28/2006US7019122 Nucleic acid sequence comprises a series of genes in the order gag (group antigen), pol (polyprotein) where the pol sequence comprises an aspartic protease, an integrase and a reverse transcriptase/RNAseH.
03/28/2006US7018835 Cap independent translation enhancer linked with genetic sequence; expressed immunogen in eukaryote cell; antisense agents, vaccines for anthrax, tuberculosis, genetic vaccines; semliki forest virus immunogen, bacterial vaccine vector